MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.50
-0.85 (-6.88%)
At close: Dec 5, 2025, 4:00 PM EST
11.73
+0.23 (2.00%)
After-hours: Dec 5, 2025, 5:50 PM EST
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $53.98 million as of December 5, 2025. Its market cap has increased by 96.39% in one year.
Market Cap
53.98M
Enterprise Value
45.43M
1-Year Change
96.39%
Ranking
Category
Stock Price
$11.50
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $53.98M, a decrease of -86.03%. That is a compound annual growth rate of -37.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 57.97M | 109.91% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |